Applied DNA Sciences Files 8-K with Bylaw Amendments

Ticker: BNBX · Form: 8-K · Filed: May 29, 2025 · CIK: 744452

Sentiment: neutral

Topics: corporate-governance, filing, financials

Related Tickers: APDN

TL;DR

APDN filed an 8-K on 5/29/25 for bylaw changes & financials.

AI Summary

Applied DNA Sciences, Inc. filed an 8-K on May 29, 2025, reporting amendments to its Articles of Incorporation or Bylaws, a Regulation FD Disclosure, and Financial Statements and Exhibits. The company, incorporated in Delaware, is based in Stony Brook, NY, and operates in the testing laboratories sector.

Why It Matters

This filing indicates potential changes in the company's governance or operational structure, which could impact its strategic direction and shareholder rights.

Risk Assessment

Risk Level: low — The filing is a routine 8-K reporting standard corporate actions and financial disclosures, not indicating immediate financial distress or significant operational shifts.

Key Numbers

Key Players & Entities

FAQ

What specific amendments were made to the Articles of Incorporation or Bylaws?

The filing indicates amendments were made, but the specific details of these amendments are not provided in the provided text excerpt.

What is the nature of the Regulation FD Disclosure?

The nature of the Regulation FD Disclosure is not detailed in the provided excerpt.

What financial statements and exhibits are included in this filing?

The filing lists 'Financial Statements and Exhibits' as an item, but the specific content is not detailed in the provided excerpt.

When was Applied DNA Sciences, Inc. incorporated?

The company was incorporated in Delaware.

What is the company's fiscal year end?

The company's fiscal year ends on September 30 (0930).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 29, 2025 regarding APPLIED DNA SCIENCES INC (BNBX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing